Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
Clinical trial NCT02621333 · TERMINATED
Trial details
- NCT number
- NCT02621333
- Sponsor
- Henan Cancer Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-09-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.